Skip to main content
Veterinary Medicines

Lamulin 364.2 mg/g granules for oral solutionfor pigs

Not authorised
  • Tiamulin

Product identification

Medicine name:
Lamulin 364.2 mg/g granules for oral solutionfor pigs
Stalimox 364,2 mg/g Granulat zur Herstellung einer Lösung zum Eingeben für Schweine
Active substance:
  • Tiamulin
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tiamulin
    364.20
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Authorisation status:
  • Revoked
Authorised in:
  • Austria
Package description:
  • Available only in German
  • 1 kg polypropylene container with inner bag of LDPE.
  • 5 kg polypropylene container with inner bag of LDPE.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Kft.
  • Virbac
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00676
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0102/001

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/12/2013
Updated on: 4/10/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/12/2013
Updated on: 4/10/2023

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/12/2013
Updated on: 4/10/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."